Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Using micro-synchrotron radiation x-ray fluorescence (µ-SRXRF) for trace metal imaging in the development of MRI contrast agents for prostate cancer imaging

Journal of Trace Elements in Medicine and Biology(2022)10.1016/j.jtemb.2022.127054Source: DataRank Database

Using micro-synchrotron radiation x-ray fluorescence (µ-SRXRF) for trace metal imaging in the development of MRI contrast agents for prostate cancer imaging is a research paper published in Journal of Trace Elements in Medicine and Biology (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.22)OA: greenTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

M. Veronica Clavijo Jordan,Kalotina Geraki ORCID,André F. Martins ORCID,Sara Chirayil ORCID,A. Dean Sherry ORCID

Live enrichment

PubMed:35939923 PMC:PMC9940726 OpenAlex:https://openalex.org/W4289597545

Cancer Prevention and Research Institute of Texas

Grant: RP180178

National Institutes of Health

Grant: DK-095416

Welch Foundation

Grant: AT-584

NIDDK NIH HHS

Grant: R01 DK095416

FWCI

0.22

Citation Percentile

0.5%

Citation Trend

2024

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9940726

publisherhttps://api.elsevier.com/content/article/PII:S0946672X22001341?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0946672X22001341?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtemb.2022.127054

Fields of Study

X-ray Spectroscopy and Fluorescence AnalysisTrace Elements in HealthMRI in cancer diagnosisAnimalsContrast MediaFluorescenceGadoliniumHumansMagnetic Resonance ImagingMaleMiceProstatic NeoplasmsSpectrometry, X-Ray EmissionSynchrotronsTrace ElementsX-RaysZinc

MeSH Terms

AnimalsContrast MediaFluorescenceGadoliniumHumansMagnetic Resonance ImagingMaleProstatic NeoplasmsSpectrometry, X-Ray EmissionTrace ElementsX-RaysZincSynchrotronsMice

Keywords

Prostate cancerMagnetic resonance imagingProstateSynchrotron radiationNuclear medicineGadoliniumContrast (vision)ChemistryNuclear magnetic resonanceMaterials scienceMolecular imagingPathologyBiomedical engineeringMedicineCancerIn vivoRadiologyBiologyPhysicsOpticsZincContrast agentX-ray Fluorescence

Sustainable Development Goals

SDG 0: Good health and well-being

Using micro-synchrotron radiation x-ray fluorescence (µ-SRXRF) for trace metal imaging in the development of MRI contrast agents for prostate cancer imaging

FAIR Checklist

Authors (7)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)